Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0917816 (
mental retardation
)
15,867
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Mutations in
FAT4
gene, one of the human FAT family genes, have been identified in Van Maldergem syndrome (VMS) and Hennekam lymphangiectasia-lymphedema syndrome (HS). The
FAT4
gene encodes a large protein with extracellular cadherin repeats, EGF-like domains and Laminin G-like domains.
FAT4
plays a role in tumor suppression and planar cell polarity. Drosophila contains a human
FAT4
homologue, fat. Drosophila fat has been mainly studied with Drosophila eye and wing systems. Here, we specially knocked down Drosophila fat in nerve system. Neuron-specific knockdown of fat shortened the life span and induced the defect in locomotive abilities of adult flies. In consistent with these phenotypes, defects in synapse structure at neuromuscular junction were observed in neuron-specific fat-knockdown flies. In addition, aberrations in axonal targeting of photoreceptor neuron in third-instar larvae were also observed, suggesting that fat involves in axonal targeting. Taken together, the results indicate that Drosophila fat plays an essential role in formation and/or maintenance of neuron. Both VMS and HS show
mental retardation
and neuronal defects. We therefore consider that these two rare human diseases could possibly be caused by the defect in
FAT4
function in neuronal cells.
...
PMID:Neuron-specific knockdown of the Drosophila fat induces reduction of life span, deficient locomotive ability, shortening of motoneuron terminal branches and defects in axonal targeting. 2848 82
The atypical cadherin
FAT4
has established roles in the regulation of planar cell polarity and Hippo pathway signaling that are cell context dependent. The recent identification of
FAT4
mutations in Hennekam syndrome, features of which include lymphedema, lymphangiectasia, and
mental retardation
, uncovered an important role for
FAT4
in the lymphatic vasculature. Hennekam syndrome is also caused by mutations in collagen and calcium binding EGF domains 1 (CCBE1) and ADAM metallopeptidase with thrombospondin type 1 motif 3 (ADAMTS3), encoding a matrix protein and protease, respectively, that regulate activity of the key prolymphangiogenic VEGF-C/VEGFR3 signaling axis by facilitating the proteolytic cleavage and activation of VEGF-C. The fact that
FAT4
, CCBE1, and ADAMTS3 mutations underlie Hennekam syndrome suggested that all 3 genes might function in a common pathway. We identified
FAT4
as a target gene of GATA-binding protein 2 (GATA2), a key transcriptional regulator of lymphatic vascular development and, in particular, lymphatic vessel valve development. Here, we demonstrate that
FAT4
functions in a lymphatic endothelial cell-autonomous manner to control cell polarity in response to flow and is required for lymphatic vessel morphogenesis throughout development. Our data reveal a crucial role for
FAT4
in lymphangiogenesis and shed light on the mechanistic basis by which
FAT4
mutations underlie a human lymphedema syndrome.
...
PMID:Atypical cadherin FAT4 orchestrates lymphatic endothelial cell polarity in response to flow. 3218 15